| RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up RA Padua, BA Guinn, AI Al-Sabah, M Smith, C Taylor, T Pettersson, ... Leukemia 12 (6), 887-892, 1998 | 272 | 1998 |
| IL‐17‐producing CD4+ T cells, pro‐inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome SY Kordasti, B Afzali, Z Lim, W Ingram, J Hayden, L Barber, K Matthews, ... British journal of haematology 145 (1), 64-72, 2009 | 239 | 2009 |
| Signs and symptoms preceding the diagnosis of Alzheimer’s disease: a systematic scoping review of literature from 1937 to 2016 F Bature, B Guinn, D Pang, Y Pappas BMJ open 7 (8), e015746, 2017 | 231 | 2017 |
| Role of 4-1BB: 4-1BB ligand in cancer immunotherapy ATC Cheuk, GJ Mufti, B Guinn Cancer gene therapy 11 (3), 215-226, 2004 | 191 | 2004 |
| 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine B Guinn, MA DeBenedette, TH Watts, NL Berinstein The Journal of Immunology 162 (8), 5003-5010, 1999 | 168 | 1999 |
| Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy ZR Yang, HF Wang, J Zhao, YY Peng, J Wang, BA Guinn, LQ Huang Cancer gene therapy 14 (7), 599-615, 2007 | 167 | 2007 |
| Leukemia-associated antigens are critical for the proliferation of acute myeloid leukemia cells J Greiner, L Bullinger, B Guinn, H Döhner, M Schmitt Clinical Cancer Research 14 (22), 7161-7166, 2008 | 127 | 2008 |
| Frequent expression of HAGE in presentation chronic myeloid leukaemias SP Adams, SS Sahota, A Mijovic, B Czepulkowski, RA Padua, GJ Mufti, ... Leukemia 16 (11), 2238-2242, 2002 | 108 | 2002 |
| Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia B Guinn, EA Bland, U Lodi, AP Liggins, K Tobal, S Petters, JW Wells, ... Biochemical and biophysical research communications 335 (4), 1293-1304, 2005 | 102 | 2005 |
| Viral vectors in cancer immunotherapy: which vector for which strategy? SA Collins, B Guinn, PT Harrison, MF Scallan, GC O'Sullivan, M Tangney Current gene therapy 8 (2), 66-78, 2008 | 101 | 2008 |
| Phenotypic and functional changes in glial cells as a function of age HY Wai, L Go, BA Guinn, PE Fraser, D Westaway, JA McLaurin Neurobiology of aging 23 (1), 105-115, 2002 | 84 | 2002 |
| 4-1BBL enhances anti-tumor responses in the presence or absence of CD28 but CD28 is required for protective immunity against parental tumors BA Guinn, EM Bertram, MA DeBenedette, NL Berinstein, TH Watts Cellular Immunology 210 (1), 56-65, 2001 | 62 | 2001 |
| Urine biomarkers for the early detection of ovarian cancer–are we there yet? K Grayson, E Gregory, G Khan, BA Guinn Biomarkers in cancer 11, 1179299X19830977, 2019 | 58 | 2019 |
| International progress in cancer gene therapy BA Guinn, R Mulherkar Cancer gene therapy 15 (12), 765-775, 2008 | 54 | 2008 |
| Recent advances and current challenges in tumor immunology and immunotherapy B Guinn, N Kasahara, F Farzaneh, NA Habib, JS Norris, AB Deisseroth Molecular Therapy 15 (6), 1065-1071, 2007 | 49 | 2007 |
| p53 mutations, methylation and genomic instability in the progression of chronic myeloid leukaemia BA Guinn, KI Mills Leukemia & lymphoma 26 (3-4), 211-226, 1997 | 47 | 1997 |
| An immune edited tumour versus a tumour edited immune system: prospects for immune therapy of acute myeloid leukaemia L Chan, NR Hardwick, B Guinn, D Darling, J Gäken, J Galea-Lauri, AY Ho, ... Cancer Immunology, Immunotherapy 55, 1017-1024, 2006 | 43 | 2006 |
| Microarray analysis of tumour antigen expression in presentation acute myeloid leukaemia B Guinn, AF Gilkes, E Woodward, NB Westwood, GJ Mufti, D Linch, ... Biochemical and biophysical research communications 333 (3), 703-713, 2005 | 39 | 2005 |
| Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia ELJ Smits, C Lee, N Hardwick, S Brooks, VFI Van Tendeloo, K Orchard, ... Cancer Immunology, Immunotherapy 60, 757-769, 2011 | 38 | 2011 |
| Elevated expression of the leukemia-associated antigen SSX2IP predicts survival in acute myeloid leukemia patients who lack detectable cytogenetic rearrangements B Guinn, J Greiner, M Schmitt, KI Mills Blood, The Journal of the American Society of Hematology 113 (5), 1203-1204, 2009 | 33 | 2009 |
Ghulam MuftiProfessor of Haemato-Oncology, King's CollegeVerified email at kcl.ac.uk
